Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Conducting Design Reviews

Posted on By

SOP for Conducting Design Reviews

Comprehensive Guide to Conducting Design Reviews for Medical Devices

1) Purpose

The purpose of this SOP is to define a structured process for conducting design reviews during the development of medical devices. Design reviews ensure that the device meets user needs, safety standards, and regulatory requirements while identifying and addressing potential issues early in the development process.

2) Scope

This SOP applies to all medical devices under development, covering all stages of design, including concept, detailed design, and final validation. It is relevant to product development, engineering, quality assurance, and regulatory affairs teams.

3) Responsibilities

– Product Development Team: Prepares design documentation and presents designs for review.
– Design Review Team: Evaluates the design, identifies risks, and suggests improvements.
– Quality Assurance (QA): Ensures compliance with design controls and regulatory requirements.
– Regulatory Affairs: Verifies alignment with applicable standards and guidelines.
– Document Control Team: Maintains records of design review meetings and outcomes.

4) Procedure

4.1 Planning Design Reviews
4.1.1 Establishing Review Phases
– Schedule design reviews at key development milestones, including:
– Concept Review: Evaluate the feasibility of initial designs.
– Detailed Design Review: Assess detailed specifications and technical drawings.
– Final Design Review: Confirm readiness for

validation and production.

See also  SOP for Disposal of Rejected or Scrap Materials

4.1.2 Assembling the Review Team
– Form a multidisciplinary review team comprising:
– Product designers and engineers.
– QA and risk management representatives.
– Regulatory experts.
– Clinical advisors (if necessary).
– Assign a chairperson to facilitate the review process.

4.2 Conducting the Design Review
4.2.1 Preparing for the Review
– Provide all team members with relevant design documentation in advance, such as:
– User needs and requirement specifications.
– Risk assessments and hazard analyses.
– Functional and technical specifications.
– Prototypes, models, or simulations.

4.2.2 Review Meeting Agenda
– Structure the meeting as follows:
– Introduction: Define the purpose and objectives of the review.
– Presentation: Product development team presents the design.
– Evaluation: Team evaluates the design against requirements and identifies risks.
– Discussion: Team discusses findings, suggestions, and corrective actions.
– Conclusion: Summarize outcomes and agree on next steps.

4.2.3 Evaluation Criteria
– Evaluate the design based on:
– Compliance with user needs and functional specifications.
– Risk management considerations (e.g., ISO 14971 compliance).
– Feasibility of manufacturing and production.
– Adherence to regulatory requirements (e.g., FDA, EU MDR).

4.3 Documenting the Design Review
4.3.1 Review Summary Report
– Document the following in a Design Review Report:
– Date, time, and location of the review.
– Names and roles of participants.
– Key discussion points and identified issues.
– Decisions made and actions assigned.
– Ensure the report is reviewed and approved by the team.

See also  SOP for Developing Packaging Specifications for Medical Devices

4.3.2 Action Items and Follow-Up
– Record action items, including:
– Specific issues to be addressed.
– Assigned responsibilities.
– Deadlines for resolution.
– Track progress and ensure closure of all actions before proceeding to the next phase.

4.4 Managing Changes and Updates
4.4.1 Revisiting Design Reviews
– Conduct additional reviews if:
– Significant design changes occur.
– New risks or regulatory updates are identified.
– Update the review summary report and associated documentation as needed.

4.4.2 Change Control
– Log design changes in the Change Control Log and assess their impact on:
– Design outputs.
– Risk management plans.
– Validation and verification processes.

4.5 Verification and Validation
4.5.1 Design Verification
– Confirm that design outputs meet input requirements through:
– Prototype testing.
– Simulation studies.
– Inspection of technical drawings.

4.5.2 Design Validation
– Validate that the final product fulfills user needs and intended use through:
– Clinical evaluations.
– Usability testing.
– Real-world performance monitoring.

4.5.3 Traceability
– Maintain a traceability matrix linking design inputs, outputs, and review findings.

4.6 Documentation and Record Keeping

4.6.1 Design Review File
– Maintain a file containing:
– Design Review Reports.
– Action Item Logs.
– Change Control Logs.
– Validation and verification records.
– Ensure version control and secure access to documents.

See also  SOP for Documenting Software Development in Medical Devices

4.6.2 Retention Period
– Retain design review records for a minimum of five years or as required by regulatory bodies.

5) Abbreviations

– FDA: Food and Drug Administration
– EU MDR: European Medical Device Regulation
– QA: Quality Assurance
– SOP: Standard Operating Procedure
– ISO: International Organization for Standardization

6) Documents

– Design Review Report
– Action Item Log
– Change Control Log
– Traceability Matrix
– Validation and Verification Records

7) Reference

– FDA CFR Title 21, Part 820: Design Controls
– ISO 14971: Application of Risk Management to Medical Devices
– ISO 13485: Medical Devices – Quality Management Systems
– EU MDR (Regulation (EU) 2017/745): General Safety and Performance Requirements

8) SOP Version

– Version: 1.0
– Effective Date: DD/MM/YYYY
– Approved by: [Name/Title]

Annexure

Annexure 1: Design Review Report Template

Date Design Phase Participants Key Findings Action Items
DD/MM/YYYY Concept Review Development Team, QA, Regulatory Material selection requires review Identify alternatives by next meeting

Annexure 2: Action Item Log Template

Action ID Description Assigned To Deadline Status
AI-001 Update design to improve durability Engineering Team DD/MM/YYYY In Progress
Medical Devices Tags:FDA Medical device SOP requirements, GMP SOP for medical devices, ISO 13485 SOP for Medical device, Medical device compliance SOP, Medical device packaging SOP template, Medical device post-market surveillance SOP, Medical device quality control SOP, Medical device quality SOP, Medical device regulatory SOP, Medical device SOP, SOP for change control in medical device, SOP for device design control, SOP for equipment calibration in medical devices, SOP for handling complaints in medical devices, SOP for manufacturing medical devices, SOP for medical device audits, SOP for medical device inspection, SOP for medical device labeling, SOP for medical device manufacturing, SOP for medical device packaging inspection, SOP for Medical device raw material, SOP for medical device testing, SOP for non-conforming products in medical devices, SOP for packaging medical devices, SOP for product validation, SOP for production planning in medical devices, SOP for risk management in medical devices, SOP for sterilization packaging validation, SOP for sterilization process of Medical device, SOP for traceability in medical device manufacturing

Post navigation

Previous Post: SOP for Creating Engineering Drawings and Specifications
Next Post: SOP for Performing Risk-Benefit Analysis of Medical Devices

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version